avatar
NSC Eb1b 140 Approved (baozi)# Immigration - 落地生根
s*p
1
ND Aug9
AD Oct21, no pp, no RFE
US PhD. Working for a company >3 years. About 10 papers (~5 first author), 3
conf. (no first author). >300 citations (>200 from non-first author papers)
. 2 patent applications, ~5 granted chinese patents. ~10 reviews. 6 referree
(1 from my company, 1 from my advisor, others are from unknown professors).
Got a lot of learnings from this board, have only 10 baozi, will transfer
them to the board, need Laoda's help for distribution. I think the most
important trick is RP,:-)
avatar
s*r
2
gongxi
avatar
Q*0
3
Congratulations!
avatar
m*s
4
GX! Best wishes!
avatar
w*y
5
gx
avatar
J*u
6
gx

3
papers)
referree
).

【在 s**p 的大作中提到】
: ND Aug9
: AD Oct21, no pp, no RFE
: US PhD. Working for a company >3 years. About 10 papers (~5 first author), 3
: conf. (no first author). >300 citations (>200 from non-first author papers)
: . 2 patent applications, ~5 granted chinese patents. ~10 reviews. 6 referree
: (1 from my company, 1 from my advisor, others are from unknown professors).
: Got a lot of learnings from this board, have only 10 baozi, will transfer
: them to the board, need Laoda's help for distribution. I think the most
: important trick is RP,:-)

avatar
l*7
7
GXGX
avatar
c*g
8
恭喜恭喜!

author), 3
papers)
referree
professors).
transfer

【在 s**p 的大作中提到】
: ND Aug9
: AD Oct21, no pp, no RFE
: US PhD. Working for a company >3 years. About 10 papers (~5 first author), 3
: conf. (no first author). >300 citations (>200 from non-first author papers)
: . 2 patent applications, ~5 granted chinese patents. ~10 reviews. 6 referree
: (1 from my company, 1 from my advisor, others are from unknown professors).
: Got a lot of learnings from this board, have only 10 baozi, will transfer
: them to the board, need Laoda's help for distribution. I think the most
: important trick is RP,:-)

avatar
c*u
9
gongxi!

author), 3
papers)
referree
professors).
transfer

【在 s**p 的大作中提到】
: ND Aug9
: AD Oct21, no pp, no RFE
: US PhD. Working for a company >3 years. About 10 papers (~5 first author), 3
: conf. (no first author). >300 citations (>200 from non-first author papers)
: . 2 patent applications, ~5 granted chinese patents. ~10 reviews. 6 referree
: (1 from my company, 1 from my advisor, others are from unknown professors).
: Got a lot of learnings from this board, have only 10 baozi, will transfer
: them to the board, need Laoda's help for distribution. I think the most
: important trick is RP,:-)

avatar
G*4
10
强力恭喜!

author), 3
papers)
referree
professors).
transfer

【在 s**p 的大作中提到】
: ND Aug9
: AD Oct21, no pp, no RFE
: US PhD. Working for a company >3 years. About 10 papers (~5 first author), 3
: conf. (no first author). >300 citations (>200 from non-first author papers)
: . 2 patent applications, ~5 granted chinese patents. ~10 reviews. 6 referree
: (1 from my company, 1 from my advisor, others are from unknown professors).
: Got a lot of learnings from this board, have only 10 baozi, will transfer
: them to the board, need Laoda's help for distribution. I think the most
: important trick is RP,:-)

avatar
w*s
11
恭喜!
avatar
w*j
12
GONG!!
avatar
z*a
13
gx
avatar
z*a
14
gx
avatar
Y*n
15
gongxi
avatar
S*9
16
GXGX
avatar
s*r
17
Congratulations!

3
papers)
referree
).

【在 s**p 的大作中提到】
: ND Aug9
: AD Oct21, no pp, no RFE
: US PhD. Working for a company >3 years. About 10 papers (~5 first author), 3
: conf. (no first author). >300 citations (>200 from non-first author papers)
: . 2 patent applications, ~5 granted chinese patents. ~10 reviews. 6 referree
: (1 from my company, 1 from my advisor, others are from unknown professors).
: Got a lot of learnings from this board, have only 10 baozi, will transfer
: them to the board, need Laoda's help for distribution. I think the most
: important trick is RP,:-)

avatar
w*c
18
gx!
avatar
b*r
19
cong
avatar
A*d
20
GXGX
avatar
a*z
21
GXGX
avatar
a*q
22
Congratulations!!!
avatar
t*n
23
Congratulations!!!
avatar
e*c
24
Congratulations and thanks for sharing!

3
papers)
referree
).

【在 s**p 的大作中提到】
: ND Aug9
: AD Oct21, no pp, no RFE
: US PhD. Working for a company >3 years. About 10 papers (~5 first author), 3
: conf. (no first author). >300 citations (>200 from non-first author papers)
: . 2 patent applications, ~5 granted chinese patents. ~10 reviews. 6 referree
: (1 from my company, 1 from my advisor, others are from unknown professors).
: Got a lot of learnings from this board, have only 10 baozi, will transfer
: them to the board, need Laoda's help for distribution. I think the most
: important trick is RP,:-)

avatar
e*c
25
Congratulations and thanks for sharing!

3
papers)
referree
).

【在 s**p 的大作中提到】
: ND Aug9
: AD Oct21, no pp, no RFE
: US PhD. Working for a company >3 years. About 10 papers (~5 first author), 3
: conf. (no first author). >300 citations (>200 from non-first author papers)
: . 2 patent applications, ~5 granted chinese patents. ~10 reviews. 6 referree
: (1 from my company, 1 from my advisor, others are from unknown professors).
: Got a lot of learnings from this board, have only 10 baozi, will transfer
: them to the board, need Laoda's help for distribution. I think the most
: important trick is RP,:-)

avatar
m*s
26
cong!

3
papers)
referree
).

【在 s**p 的大作中提到】
: ND Aug9
: AD Oct21, no pp, no RFE
: US PhD. Working for a company >3 years. About 10 papers (~5 first author), 3
: conf. (no first author). >300 citations (>200 from non-first author papers)
: . 2 patent applications, ~5 granted chinese patents. ~10 reviews. 6 referree
: (1 from my company, 1 from my advisor, others are from unknown professors).
: Got a lot of learnings from this board, have only 10 baozi, will transfer
: them to the board, need Laoda's help for distribution. I think the most
: important trick is RP,:-)

avatar
b*s
27
Cong!
avatar
L*y
28
gxgx
avatar
p*i
29
gxgx
avatar
h*5
30
GXGX

3
papers)
referree
).

【在 s**p 的大作中提到】
: ND Aug9
: AD Oct21, no pp, no RFE
: US PhD. Working for a company >3 years. About 10 papers (~5 first author), 3
: conf. (no first author). >300 citations (>200 from non-first author papers)
: . 2 patent applications, ~5 granted chinese patents. ~10 reviews. 6 referree
: (1 from my company, 1 from my advisor, others are from unknown professors).
: Got a lot of learnings from this board, have only 10 baozi, will transfer
: them to the board, need Laoda's help for distribution. I think the most
: important trick is RP,:-)

avatar
y*h
31
bless
avatar
m*g
32
GX
avatar
G*0
33
GXGX

3
papers)
referree
).

【在 s**p 的大作中提到】
: ND Aug9
: AD Oct21, no pp, no RFE
: US PhD. Working for a company >3 years. About 10 papers (~5 first author), 3
: conf. (no first author). >300 citations (>200 from non-first author papers)
: . 2 patent applications, ~5 granted chinese patents. ~10 reviews. 6 referree
: (1 from my company, 1 from my advisor, others are from unknown professors).
: Got a lot of learnings from this board, have only 10 baozi, will transfer
: them to the board, need Laoda's help for distribution. I think the most
: important trick is RP,:-)

avatar
Y*Z
34
gxgx
avatar
l*t
35
congrats
avatar
m*n
36
cong
avatar
u*g
37
Congratulations!
avatar
S*8
38
Congratulations!
Baozi
avatar
t*o
39
gxgx!
avatar
l*y
40
congrats!!!!!!!
avatar
k*y
41
大大的恭喜!!!
avatar
p*t
42
avatar
H*e
43
GXGX
avatar
R*n
44
GXGX
avatar
d*g
45
Gongxi
avatar
m*3
46
congrats!
avatar
p*l
47
GX
avatar
M*g
48
cong and zhan
bless us all!

3
papers)
referree
).

【在 s**p 的大作中提到】
: ND Aug9
: AD Oct21, no pp, no RFE
: US PhD. Working for a company >3 years. About 10 papers (~5 first author), 3
: conf. (no first author). >300 citations (>200 from non-first author papers)
: . 2 patent applications, ~5 granted chinese patents. ~10 reviews. 6 referree
: (1 from my company, 1 from my advisor, others are from unknown professors).
: Got a lot of learnings from this board, have only 10 baozi, will transfer
: them to the board, need Laoda's help for distribution. I think the most
: important trick is RP,:-)

avatar
d*0
49
Nebraska?
avatar
m*e
50
恭喜,恭喜
avatar
d*e
51
GXGX!
avatar
h*l
52
con
相关阅读
logo
联系我们隐私协议©2024 redian.news
Redian新闻
Redian.news刊载任何文章,不代表同意其说法或描述,仅为提供更多信息,也不构成任何建议。文章信息的合法性及真实性由其作者负责,与Redian.news及其运营公司无关。欢迎投稿,如发现稿件侵权,或作者不愿在本网发表文章,请版权拥有者通知本网处理。